Publications Database

Akhondzadeh S. et al. (2008)

A double-blind placebo controlled trial of piracetam added to risperidone in patients with autistic disorder.

Child Psychiatry and Human Development

39(3), pp. 237-245

Read Abstract (New Window)

Akhondzadeh S. et al. (2004)

Cyproheptadine in the treatment of autistic disorder: a double-blind placebo-controlled trial.

Journal of Clinical Pharmacy and Therapeutics

29(2), pp.145-150

Read Abstract (New Window)

Akhondzadeh S. et al. (2010)

Double-blind placebo controlled trial of pentoxifylline added to risperidone: Effects on aberrant behavior in children with autism.

Progress in Neuro-Psychopharmacology and Biological Psychiatry

34(1), pp. 32-36

Read Abstract (New Window)

Asadabadi M. et al. (2013)

Celecoxib as adjunctive treatment to risperidone in children with autistic disorder: a randomized, double-blind, placebo-controlled trial.

Psychopharmacology (Berl)

225(1), pp. 51-59.

Read Abstract (New Window)

Ghaleiha A. et al. (2015)

A pilot double-blind placebo-controlled trial of pioglitazone as adjunctive treatment to risperidone: Effects on aberrant behavior in children with autism.

Psychiatry Research

Read Abstract (New Window)

Ghaleiha A. et al. (2013)

Galantamine efficacy and tolerability as an augmentative therapy in autistic children: A randomized, double-blind, placebo-controlled trial.

Journal of Psychopharmacology

October, 28(7), pp. 677-685.

Read Abstract (New Window)

Ghaleiha A. et al. (2013)

Memantine as adjunctive treatment to risperidone in children with autistic disorder: a randomized, double-blind, placebo-controlled trial.

International Journal of Neuropsycholpharmacology

16(4), pp. 783-789.

Read Abstract (New Window)

Ghaleiha A. et al. (2013)

Riluzole as an adjunctive therapy to risperidone for the treatment of irritability in children with autistic disorder: A double-blind, placebo-controlled, randomized trial.

Pediatric Drugs

15(6), pp. 505-514.

Read Abstract (New Window)

Mohammadi M. et al. (2013)

Double-blind, placebo-controlled trial of risperidone plus amantadine in children with autism: a 10-week randomized study.

Clinical Neuropharmacology

36(6), pp. 179-184.

Read Abstract (New Window)

Rezaei V. et al. (2010)

Double-blind, placebo-controlled trial of risperidone plus topiramate in children with autistic disorder.

Progress in Neuro-Psychopharmacology and Biological Psychiatry

34(7), pp. 1269-1272.

Read Abstract (New Window)